1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Headaches

Botulinum toxin type A for the prevention of headaches in adults with chronic migraine

Technology appraisal guidance [TA260] Published date: 27 June 2012

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
  • Overview
  • 1 Guidance
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Related NICE guidance
  • 7 Review of guidance
  • Appendix A: Appraisal Committee members, guideline representatives and NICE project team
  • Appendix B: Sources of evidence considered by the Committee
  • Changes after publication
  • About this guidance
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...
  • Download

Guidance

  • Next

6 Related NICE guidance

  • Published
  • Under development

6 Related NICE guidance

Published

  • Percutaneous closure of patent foramen ovale for recurrent migraine. NICE interventional procedure guidance 370 (2010).

  • Deep brain stimulation for intractable trigeminal autonomic cephalalgias. NICE interventional procedure guidance 381 (2011).

Under development

NICE is developing the following guidance (details available from www.nice.org.uk):

  • Diagnosis and management of headaches in young people and adults. NICE clinical guideline. Expected date of publication September 2012.

  • National Institute for Health and Care Excellence (NICE)

  • Next